These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
996 related items for PubMed ID: 22056404
1. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404 [Abstract] [Full Text] [Related]
2. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [Abstract] [Full Text] [Related]
3. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476 [Abstract] [Full Text] [Related]
4. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF. Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126 [Abstract] [Full Text] [Related]
5. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y. Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764 [Abstract] [Full Text] [Related]
6. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI. J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151 [Abstract] [Full Text] [Related]
7. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M. Ann Acad Med Stetin; 2000 Sep 20; 46():217-29. PubMed ID: 11712306 [Abstract] [Full Text] [Related]
8. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW. J Urol; 2007 Dec 20; 178(6):2308-12; discussion 2313. PubMed ID: 17936804 [Abstract] [Full Text] [Related]
9. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Urol Oncol; 2014 Feb 20; 32(2):117-27. PubMed ID: 23477878 [Abstract] [Full Text] [Related]
11. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. J Urol; 2012 Apr 20; 187(4):1210-4. PubMed ID: 22335861 [Abstract] [Full Text] [Related]
12. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Soave A, Dahlem R, Hansen J, Weisbach L, Minner S, Engel O, Kluth LA, Chun FK, Shariat SF, Fisch M, Rink M. Eur J Surg Oncol; 2015 Mar 20; 41(3):368-77. PubMed ID: 24674298 [Abstract] [Full Text] [Related]
13. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y. J Urol; 2009 Jul 20; 182(1):78-84; discussion 84. PubMed ID: 19447418 [Abstract] [Full Text] [Related]
14. Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study. Neuzillet Y, Soulie M, Larre S, Roupret M, Defortescu G, Murez T, Pignot G, Descazeaud A, Patard JJ, Bigot P, Salomon L, Colin P, Rigaud J, Bastide C, Durand X, Valeri A, Kleinclauss F, Bruyere F, Pfister C, Comité de Cancérologie de l'Association Française d'Urologie (CCAFU). BJU Int; 2013 Jun 20; 111(8):1253-60. PubMed ID: 23331375 [Abstract] [Full Text] [Related]
15. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G. BJU Int; 2013 Jul 20; 112(1):54-9. PubMed ID: 23146082 [Abstract] [Full Text] [Related]
16. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, Kaushik D, Frank I. J Urol; 2013 Dec 20; 190(6):2005-10. PubMed ID: 23770147 [Abstract] [Full Text] [Related]
17. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Soave A, John LM, Dahlem R, Minner S, Engel O, Schmidt S, Kluth LA, Fisch M, Rink M. Urology; 2015 Jul 20; 86(1):92-8. PubMed ID: 26051839 [Abstract] [Full Text] [Related]
18. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy. May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A. Ann Surg Oncol; 2014 Nov 20; 21(12):4034-40. PubMed ID: 24895114 [Abstract] [Full Text] [Related]
19. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder. Vallo S, Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM, Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A, Fisch M, Aziz A. Urol Oncol; 2016 Oct 20; 34(10):432.e1-8. PubMed ID: 27283218 [Abstract] [Full Text] [Related]
20. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A. BJU Int; 2013 Jun 20; 111(8):1215-21. PubMed ID: 23181623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]